LRP8 and neoplasm: Using the WT or Lrp8-KO LLC model in WT and Spon1–/– mice, we found significantly decreased tumor burden by IVIS in WT mice with Lrp8-KO tumors, and a significantly diseased metastatic burden in the when both SPON1 and LRP8 are knocked out (Figure 6F).